Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for Symptomatic Chronic Functional Tricuspid Regurgitation

NCT03225612 is registered in ClinicalTrials.gov with Mitralign, Inc. as lead sponsor.

NCT NCT03225612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03225612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for Symptomatic Chronic Functional Tricuspid Regurgitation
Lead sponsor
Mitralign, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
May 22, 2017
Completion date
November 30, 2022
Enrollment
60 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic symptomatic functional tricuspid regurgitation, heart valve disease, tricuspid valve insufficiency